Laurus Labs Limited IPO
Laurus Labs Limited was a mainboard IPO in the Pharmaceuticals sector, offered at ₹85.2–₹85.6 per share to raise ₹300 crore. The issue was subscribed 4.57× overall (QIBs 10.54×, NIIs 3.58×, retail 1.67×). It listed on 19 Dec 2016 at ₹98 and closed its first day at ₹96, a listing gain of +12.2% versus the ₹85.6 issue price. It now trades around ₹2,406 (+2710.2% versus the issue price).
Frequently asked questions
- How many times was the Laurus Labs Limited IPO subscribed?
- The Laurus Labs Limited IPO was subscribed 4.57× overall — 10.54× in the QIB category, 3.58× among non-institutional investors, 1.67× in retail.
- What were the Laurus Labs Limited IPO listing gains?
- Laurus Labs Limited listed on 19 Dec 2016 at ₹98, closing its first day at ₹96 — a listing gain of +12.2% versus the ₹85.6 issue price.
- What were the retail allotment odds for the Laurus Labs Limited IPO?
- Retail was subscribed 1.67×, so a single-lot application had roughly a 59.9% chance of allotment (about 1 in 2), and allotment was finalised on 13 Dec 2016.
- What was the price band and lot size of the Laurus Labs Limited IPO?
- The price band was ₹85.2–₹85.6 per share, with a minimum lot of 35 shares (₹2,996 at the upper band).
- Who were the registrar and lead manager for the Laurus Labs Limited IPO?
- Karvy Computershare Private Limited was the registrar, and Kotak Mahindra Capital was the book-running lead manager.